Renal Cancer
-
ASCO21 Meeting Summary – Kidney Cancer
Practice Changing Results in RCC come from ASCO 2021 Ochsner Precision Cancer Therapies Program and Ochsner Cancer Institute, Benson Cancer…
Read More » -
ASCO21 Sessions: RECOMMENDED ABSTRACTS in Renal Cancer
These recommended abstracts have been selected by Robert A. Figlin, MD, Editor-in- Chief of the Kidney Cancer Journal. The chosen abstracts provided…
Read More » -
MEDICAL INTELLIGENCE – Kidney Cancer
Newsworthy, late-breaking kidney cancer information from Web-based sources, professional societies, and government agencies FDA Approves Tivozanib as First Therapy for…
Read More » -
Editor’s Memo
Robert A. Figlin MD Novel Drug Combinations Gain Traction Across Therapeutic Landscape More than a year since the COVID-19 crisis…
Read More » -
Updated NCCN Guideline Recommends Tivozanib Regimen in Clear Cell Renal Cell Carcinoma
Christoph Baker Mar 29 | 2021 National Comprehensive Cancer Network (NCCN) has updated its Clinical Practice Guidelines to include FOTIVDA® (tivozanib)…
Read More » -
Guidelines for Kidney Cancer Treatment
A list of global guidelines for kidney cancer are provided in this section. These guidelines provide evidence-based recommendations to serve as a guide…
Read More »
